Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity.

Frontiers in endocrinology

Atteia HH, Alzahrani S, El-Sherbeeny NA, Youssef AM, Farag NE, Mehanna ET, Elhawary R, Ibrahim GA, Elmistekawy A, Zaitone SA.
PMID: 32082253
Front Endocrinol (Lausanne). 2020 Jan 30;10:942. doi: 10.3389/fendo.2019.00942. eCollection 2019.

Obesity is a public health burden disturbing all body functions and reproductive hormones. As obesity increases among females, there will be a rising challenge to physicians in care from fertility problems. Evening primrose oil (EPR oil) contains essential fatty...

Cite
Atteia HH, Alzahrani S, El-Sherbeeny NA, et al. Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity. Front Endocrinol (Lausanne). 2020;10:942doi: 10.3389/fendo.2019.00942.
Atteia, H. H., Alzahrani, S., El-Sherbeeny, N. A., Youssef, A. M., Farag, N. E., Mehanna, E. T., Elhawary, R., Ibrahim, G. A., Elmistekawy, A., & Zaitone, S. A. (2019). Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity. Frontiers in endocrinology, 10942. https://doi.org/10.3389/fendo.2019.00942
Atteia, Hebatallah H, et al. "Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity." Frontiers in endocrinology vol. 10 (2019): 942. doi: https://doi.org/10.3389/fendo.2019.00942
Atteia HH, Alzahrani S, El-Sherbeeny NA, Youssef AM, Farag NE, Mehanna ET, Elhawary R, Ibrahim GA, Elmistekawy A, Zaitone SA. Evening Primrose Oil Ameliorates Hyperleptinemia and Reproductive Hormone Disturbances in Obese Female Rats: Impact on Estrus Cyclicity. Front Endocrinol (Lausanne). 2020 Jan 30;10:942. doi: 10.3389/fendo.2019.00942. eCollection 2019. PMID: 32082253; PMCID: PMC7002433.
Copy Download .nbib Format: NLM
Overexpression of Adiponectin Receptors in Opium Users with and without Cancer.

Clinical pharmacology : advances and applications

Firouzabadi N, Haghnegahdar M, Khalvati B, Dehshahri A, Bahramali E.
PMID: 32607004
Clin Pharmacol. 2020 Jun 15;12:59-65. doi: 10.2147/CPAA.S256289. eCollection 2020.

AIM: Opium addiction is a serious public health concern in the Middle East countries causing various illnesses. Opium use is associated with an increased risk of several cancers; however, the underlying mechanisms are not yet fully elucidated. Altered levels...

Cite
Firouzabadi N, Haghnegahdar M, Khalvati B, et al. Overexpression of Adiponectin Receptors in Opium Users with and without Cancer. Clin Pharmacol. 2020;12:59-65doi: 10.2147/CPAA.S256289.
Firouzabadi, N., Haghnegahdar, M., Khalvati, B., Dehshahri, A., & Bahramali, E. (2020). Overexpression of Adiponectin Receptors in Opium Users with and without Cancer. Clinical pharmacology : advances and applications, 1259-65. https://doi.org/10.2147/CPAA.S256289
Firouzabadi, Negar, et al. "Overexpression of Adiponectin Receptors in Opium Users with and without Cancer." Clinical pharmacology : advances and applications vol. 12 (2020): 59-65. doi: https://doi.org/10.2147/CPAA.S256289
Firouzabadi N, Haghnegahdar M, Khalvati B, Dehshahri A, Bahramali E. Overexpression of Adiponectin Receptors in Opium Users with and without Cancer. Clin Pharmacol. 2020 Jun 15;12:59-65. doi: 10.2147/CPAA.S256289. eCollection 2020. PMID: 32607004; PMCID: PMC7304683.
Copy Download .nbib Format: NLM
Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.

Current pathobiology reports

Park PH, Sanz-Garcia C, Nagy LE.
PMID: 26858914
Curr Pathobiol Rep. 2015 Dec 01;3(4):243-252. doi: 10.1007/s40139-015-0094-y. Epub 2015 Sep 30.

Hepatic fibrosis is a dynamic process resulting from excessive deposition of extracellular matrix in the liver; uncontrolled progression of fibrosis can eventually lead to liver cirrhosis and/or hepatocellular carcinoma. The fibrogenic process is complex and modulated by a number...

Cite
Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 2015;3(4):243-252doi: 10.1007/s40139-015-0094-y.
Park, P. H., Sanz-Garcia, C., & Nagy, L. E. (2015). Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Current pathobiology reports, 3(4), 243-252. https://doi.org/10.1007/s40139-015-0094-y
Park, Pil-Hoon, et al. "Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver." Current pathobiology reports vol. 3,4 (2015): 243-252. doi: https://doi.org/10.1007/s40139-015-0094-y
Park PH, Sanz-Garcia C, Nagy LE. Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep. 2015 Dec 01;3(4):243-252. doi: 10.1007/s40139-015-0094-y. Epub 2015 Sep 30. PMID: 26858914; PMCID: PMC4743902.
Copy Download .nbib Format: NLM
Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china.

Hepatitis monthly

Wu D, Li H, Xiang G, Zhang L, Li L, Cao Y, Zhang J.
PMID: 23914225
Hepat Mon. 2013 Apr 18;13(4):e6065. doi: 10.5812/hepatmon.6065. Print 2013 Apr.

BACKGROUND: HBV infection is a serious public health problem worldwide, which can contribute to the incidence of chronic hepatitis B (CHB), cirrhosis, and hepatocellular carcinoma (HCC).OBJECTIVES: In the present report, we assessed the association between adiponectin, its receptors and...

Cite
Wu D, Li H, Xiang G, et al. Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china. Hepat Mon. 2013;13(4):e6065doi: 10.5812/hepatmon.6065.
Wu, D., Li, H., Xiang, G., Zhang, L., Li, L., Cao, Y., & Zhang, J. (2013). Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china. Hepatitis monthly, 13(4), e6065. https://doi.org/10.5812/hepatmon.6065
Wu, Di, et al. "Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china." Hepatitis monthly vol. 13,4 (2013): e6065. doi: https://doi.org/10.5812/hepatmon.6065
Wu D, Li H, Xiang G, Zhang L, Li L, Cao Y, Zhang J. Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china. Hepat Mon. 2013 Apr 18;13(4):e6065. doi: 10.5812/hepatmon.6065. Print 2013 Apr. PMID: 23914225; PMCID: PMC3725260.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries